DATE,PATIENT,ENCOUNTER,CODE,DESCRIPTION,BASE_COST
2016-02-13T11:16:51Z,c4037c2c-6e4d-07ee-2fd2-04dfa51d454c,eaa45e3b-9047-17b9-693c-86f94c71b11e,140,Influenza  seasonal  injectable  preservative free,136.0
2016-02-13T11:16:51Z,c4037c2c-6e4d-07ee-2fd2-04dfa51d454c,eaa45e3b-9047-17b9-693c-86f94c71b11e,113,Td (adult)  5 Lf tetanus toxoid  preservative free  adsorbed,136.0
2016-02-13T11:16:51Z,c4037c2c-6e4d-07ee-2fd2-04dfa51d454c,eaa45e3b-9047-17b9-693c-86f94c71b11e,43,Hep B  adult,136.0
2016-02-13T11:16:51Z,c4037c2c-6e4d-07ee-2fd2-04dfa51d454c,eaa45e3b-9047-17b9-693c-86f94c71b11e,114,meningococcal MCV4P,136.0
2019-02-16T11:16:51Z,c4037c2c-6e4d-07ee-2fd2-04dfa51d454c,617dc673-fed5-4074-ac18-24d954beca93,140,Influenza  seasonal  injectable  preservative free,136.0
2021-09-04T11:16:51Z,c4037c2c-6e4d-07ee-2fd2-04dfa51d454c,c3f2849b-90b8-8b8a-41c6-8a154b3fd5c2,207,COVID-19  mRNA  LNP-S  PF  100 mcg/0.5mL dose or 50 mcg/0.25mL dose,136.0
2021-10-02T11:16:51Z,c4037c2c-6e4d-07ee-2fd2-04dfa51d454c,7613e04c-d219-48c3-e3f4-b44d5cf4b44f,207,COVID-19  mRNA  LNP-S  PF  100 mcg/0.5mL dose or 50 mcg/0.25mL dose,136.0
2022-02-19T11:16:51Z,c4037c2c-6e4d-07ee-2fd2-04dfa51d454c,1ad70491-19d0-0ebc-8fe3-82d47ed81e17,140,Influenza  seasonal  injectable  preservative free,136.0
2022-04-02T11:16:51Z,c4037c2c-6e4d-07ee-2fd2-04dfa51d454c,0cea277c-b4ea-401a-8180-6f38e09afc88,140,Influenza  seasonal  injectable  preservative free,136.0
